The biotechnology firm IMMUNEONCO-B (01541) has announced a share repurchase activity.
On June 12, 2026, the company allocated HKD 8,722 to repurchase 2,600 of its own shares from the market.
The transaction was executed at a price range between HKD 3.35 and HKD 3.36 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.